LSI is Officially Heading to Singapore — Register for LSI Asia '25 Today

Neurovance

A triple reuptake inhibitor to treat adult attention deficit hyperactivity disorder (ADHD) that provides improved efficacy and reduced drug abuse liab....

Get a Demo and See the Full Profile

Get a demo today to see profiles of Neurovance plus 6131 other startups.

Learn More About Neurovance

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups

More